Delivery Order SPE2DE24DA011-SPE2D625F1WUC
- Not listed
- Arthrex Inc., a Naples, Florida-based orthopedic medical device manufacturer, was awarded a $4,260.22 fixed-price delivery order with economic price adjustment on August 21, 2025, for endoscopic spine instrument usage. The contract, which carries no set-aside designation, is scheduled for completion by September 3, 2025, and will be performed in Naples, Florida. This delivery order is funded through the Defense Logistics Agency's Medical Supply Chain division, reflecting the Department of...
- Arthrex Inc., a Naples, Florida-based orthopedic medical device manufacturer, was awarded a fixed-price delivery order valued at $4,265.22 on August 21, 2025, for endoscopic spine instrument usage. The contract, which carries no set-aside designation, was issued by the Defense Logistics Agency's Medical Supply Chain and is scheduled for completion by September 3, 2025. Performance will occur in Naples, FL. This delivery order falls under Arthrex's larger Indefinite Delivery Contract...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $3,600.22 for endoscopic spine instrument usage on August 21, 2025. This fixed-price delivery order with economic price adjustment represents work under Arthrex's larger Indefinite Delivery Contract (IDC SPE2DE24D0020) with the Defense Logistics Agency's Medical Supply Chain, valued at approximately $471 million and extending through September 1, 2029. The...
- Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies headquartered in Naples, Florida, was awarded a delivery order valued at $1,101.65 on August 15, 2025, for C-line endoscopic soft tissue release instruments. This fixed-price delivery order with economic price adjustment was issued under the Defense Logistics Agency's Medical Supply Chain, with an ultimate completion date of August 20, 2025. The award carries no set-aside designation, reflecting Arthrex's...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, has been awarded a delivery order valued at $14,287.84 for a miscellaneous instrument set under the Defense Logistics Agency's Medical Supply Chain program. The award, issued on August 13, 2025, with an ultimate completion date of August 18, 2025, is structured as a fixed-price contract with economic price adjustment provisions. This delivery order falls under Arthrex's larger single-award...
- Arthrex Inc., a leading orthopedic medical device manufacturer headquartered in Naples, Florida, was awarded a delivery order valued at $1,837.44 by the Defense Logistics Agency's Medical Supply Chain on August 4, 2025, with an ultimate completion date of August 7, 2025. This fixed-price contract with economic price adjustment represents a non-set-aside award for the delivery of orthopedic implant systems, surgical instruments, and related technologies. The delivery order falls under Arthrex's...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a fixed-price delivery order valued at $14,825.62 by the Defense Logistics Agency's Medical Supply Chain on August 28, 2025. This delivery order, which carries a ceiling value of $14,825.62 and includes economic price adjustment provisions, is scheduled for completion by September 3, 2025, and will be performed at Arthrex's Naples facility. The award represents a task order under...
- Arthrex Inc., headquartered in Naples, Florida, has been awarded a delivery order valued at $4,952.90 by the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency. The contract, which is not set aside for any specific business type, is structured as a fixed-price agreement with economic price adjustment provisions. The delivery order was executed on July 31, 2025, with an ultimate completion date of August 5, 2025, and will be performed at Arthrex's Naples, Florida...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a $34,145.28 delivery order by the Defense Logistics Agency's Medical Supply Chain on August 5, 2025, with an ultimate completion date of August 8, 2025. The contract, designated as a fixed-price delivery order with economic price adjustment provision, calls for the delivery of a Fibertak Spondylrg Implant System with Back Swivel component to support orthopedic surgical capabilities....
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, received a $6,131.10 fixed-price delivery order from the Defense Logistics Agency's Medical Supply Chain on August 15, 2025. The award, with an ultimate completion date of August 20, 2025, covers double-loaded double-flex fibertak with blue 0.9mm steel needles—specialized surgical instruments used in orthopedic procedures. This delivery order was issued without set-aside designation, reflecting...
- SPE2DE24DA011Indefinite Delivery Contract
- SPE2DE24DA011-SPE2D625F1WUCDelivery Order
The U.S. Defense Logistics Agency's Medical Supply Chain has awarded a $4,595.22 delivery order to Arthrex Inc. for endoscopic spine instrument usage. This fixed-price delivery order with economic price adjustment was issued on August 25, 2025, with an ultimate completion date of August 29, 2025. The award carries no set-aside designation, reflecting Arthrex's strong competitive standing in the federal orthopedic medical device marketplace. The work will be performed in Naples, Florida, where Arthrex maintains its global headquarters. Arthrex Inc., a Naples-based leader in minimally invasive orthopedic medical technologies, supplies advanced surgical instruments, implants, and biologics to Department of Defense and Department of Veterans Affairs healthcare systems. This delivery order is issued under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency, valued at $471.0 million and running through September 1, 2029. That comprehensive IDC enables VA medical centers nationwide to procure Arthrex's orthopedic product portfolio, including surgical implants, arthroscopic instruments, and specialized surgical systems. To date, Arthrex has received over $550,000 in task orders under this vehicle, demonstrating consistent demand for its medical device solutions across the federal healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.6k | 8/25/25 |